What Researchers Did
Researchers presented a case study of a 3-year-old girl with leukemia and rhino-orbital-cerebral mucormycosis (ROCM) and reviewed existing literature on ROCM in pediatric hematological patients.
What They Found
They found that a 3-year-old girl with acute lymphoblastic leukemia and rhino-orbital-cerebral mucormycosis (ROCM) was successfully treated. Her treatment involved extensive surgery, systemic antifungals including amphotericin B, posaconazole, and terbinafine, hyperbaric oxygen, and 114 intrathecal administrations of amphotericin B.
What This Means for Canadian Patients
This case demonstrates that aggressive, multi-modal treatment, including extensive surgery and antifungal therapy, can successfully treat severe rhino-orbital-cerebral mucormycosis in pediatric leukemia patients. Canadian clinicians treating similar high-risk pediatric patients may consider such comprehensive approaches to improve outcomes for this rare but deadly infection.
Canadian Relevance
This study does not have a direct Canadian connection as it describes a case from outside Canada.
Study Limitations
As a single case report, the findings of this study have limited generalizability to the broader population of pediatric patients with rhino-orbital-cerebral mucormycosis.